Cargando…
Point of use production of liposomal solubilised products
With the progression towards personalised and age-appropriate medicines, the production of drug loaded liposomes at the point of care would be highly desirable. In particular, liposomal solubilisation agents that can be produced rapidly and easily would provide a new option in personalised medicines...
Autores principales: | Khadke, Swapnil, Stone, Peter, Rozhin, Aleksey, Kroonen, Jerome, Perrie, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland Biomedical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821685/ https://www.ncbi.nlm.nih.gov/pubmed/29225099 http://dx.doi.org/10.1016/j.ijpharm.2017.12.012 |
Ejemplares similares
-
Application of Pharmacokinetics Modelling to Predict Human Exposure of a Cationic Liposomal Subunit Antigen Vaccine System
por: Badhan, Raj K. S., et al.
Publicado: (2017) -
The Impact of Solvent Selection: Strategies to Guide the Manufacturing of Liposomes Using Microfluidics
por: Webb, Cameron, et al.
Publicado: (2019) -
Methods for the solubilisation of membrane proteins: the micelle-aneous world of membrane protein solubilisation
por: Ratkeviciute, Giedre, et al.
Publicado: (2021) -
Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
por: Schmidt, Signe Tandrup, et al.
Publicado: (2020) -
Rapid Quantification and Validation of Lipid Concentrations within Liposomes
por: Roces, Carla B., et al.
Publicado: (2016)